FIA
ONC

FNY Investment Advisers’s BeOne Medicines Ltd ONC Stock Holding History

FNY Investment Advisers’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-500
Closed -$121K – 1582
2025
Q2 		$121K Sell
500
-2,300
-82% -$564K 0.05% 277
2025
Q1 		$762K Buy
+2,800
New +$655K 0.46% 56
2021
Q1 		– Sell
-1,000
Closed -$258K – 1060
2020
Q4 		$258K Buy
+1,000
New +$275K 0.07% 180

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FNY Investment Advisers's ONC Position: Q3 2025 in Review

FNY Investment Advisers sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 500 shares — an estimated $121K sold.

FNY Investment Advisers first reported a position in ONC in Q4 2020 and held it in 3 quarters. The position peaked at $762K in Q1 2025. 265 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • FNY Investment Advisers reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 500 BeOne Medicines Ltd shares in Q3 2025, an estimated $121K.
  • FNY Investment Advisers first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 3 quarters.
  • FNY Investment Advisers's BeOne Medicines Ltd position peaked at $762K in Q1 2025.
  • 265 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.